Your Specialty Pharmaceutical Partner

Methapharm is a full-service pharmaceutical company offering sales and marketing, regulatory services, market access, and distribution capabilities for product partnership opportunities. Operating in the United States and Canada, we are focused on the commercialization and marketing of niche pharmaceutical products and related devices in either country.

Licensed to distribute pharmaceuticals and medical devices, Methapharm’s GMP Operations make us an attractive partner to distribute legacy, niche, and hospital products from companies who do not have a presence in either the US or Canada. In addition to GMP distribution capabilities, Methapharm offers complete in-house regulatory, pharmacovigilance, sales and marketing, and market access solutions as part of what we offer our partners. Our infrastructure includes an eCTD server for regulatory submissions, pedigree solutions for US distribution, and financial and inventory reporting solutions.

Methapharm blends corporate and entrepreneurial experiences with a common sense approach towards the optimization of business outcomes. As a distribution partner, Methapharm can:

  • Assume responsibilities for a brand
  • Develop optimal strategy to maximize business outcomes
  • Efficiently manage market challenges
  • Provide flexible arrangements for relationship and deal scenarios

Mission

Methapharm's mission is to continue to grow as a specialty pharmaceutical company focused on efficiently supplying patients and practitioners with niche products requiring a high degree of contact with specialty physicians, hospitals and key opinion leaders in the United States and Canada.

Please visit the Business Development section of this website as we are actively pursuing partnerships in specific fields on which to leverage our existing sales and marketing experience.

NEWS

March 1, 2012
News Release - Methapharm Announces Canadian Distribution of Vancocin

January 9, 2012
News Release - Methapharm Receives ISO 13485 Accreditation

May 10, 2010
Methapharm appointed Canadian distributor for Kelo-cote® Advanced Scar Therapy.
Visit www.kelo-cote.ca

May 4, 2009
Methapharm appointed Canadian distributor for Erythrocin IV.
Visit www.erythrocin.ca

March 16, 2009
Methapharm appointed Canadian distributor for Dantrium IV and Capsules.
Visit www.dantrium.ca

October 21, 2008
Methapharm implements Axway’s Synchrony ePedigree solution.

March 19, 2008
Methapharm implements Lorenz docuBridge® eCTD solution.

October 1, 2007
Methapharm receives VAWD® accreditation from NABP®.

UPCOMING EVENTS

April 28, May 2, 2012
Methapharm to exhibit at the AATS 2012 Annual meeting • San Francisco, California

May 16 - 19, 2012
Methapharm to exhibit at the ILTS 18th Annual International Congress • San Francisco, California

May 20 - 23, 2012
Methapharm to exhibit at the ATS 2012 International Conference • San Francisco, California

June 2 - 6, 2012
Methapharm to exhibit at The American Transplant Congress • Boston, MA

July 15 - 19, 2012
Methapharm to exhibit at the 24th International Congress of The Transplantation Society • Berlin

September 1 - 5, 2012
Methapharm to exhibit at the European Respiratory Society Annual Conference • Vienna

October 9 - 11, 2012
Methapharm to exhibit at CPhI Worldwide • Madrid, Spain

October 20 - 25, 2012
Methapharm to exhibit at The CHEST Annual Meeting • Atlanta, GA

November 10 - 13, 2012
Methapharm to exhibit at The AARC Congress 2012 • New Orleans, Louisiana